Bellevue Group Ag Glaukos Corp Transaction History

Bellevue Group Ag

  • $5.02 Billion
  • Q4 2024

A detailed history of Bellevue Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Bellevue Group Ag holds 60,875 shares of GKOS stock, worth $6.83 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
60,875
Previous 62,983 3.35%
Holding current value
$6.83 Million
Previous $8.21 Million 11.24%
% of portfolio
0.18%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$126.42 - $152.67 $266,493 - $321,828
-2,108 Reduced 3.35%
60,875 $9.13 Million
Q3 2024

Nov 14, 2024
BUY
$113.62 - $135.39 $801,816 - $955,447
7,057 Added 12.62%
62,983 $8.21 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $4.27 Million - $5.39 Million
55,926 New
55,926 $5.27 Million
Q4 2021

Feb 10, 2022
SELL
$40.27 - $56.99 $5.79 Million - $8.2 Million
-143,870 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$47.43 - $84.23 $16.7 Million - $29.6 Million
-351,562 Reduced 70.96%
143,870 $6.93 Million
Q2 2021

Aug 12, 2021
BUY
$73.06 - $97.7 $444,935 - $594,993
6,090 Added 1.24%
495,432 $42 Million
Q1 2021

May 12, 2021
BUY
$70.43 - $97.42 $2.82 Million - $3.9 Million
40,010 Added 8.9%
489,342 $41.1 Million
Q4 2020

Feb 16, 2021
SELL
$48.9 - $75.26 $3.25 Million - $5 Million
-66,422 Reduced 12.88%
449,332 $33.8 Million
Q3 2020

Nov 16, 2020
BUY
$37.23 - $50.97 $816,937 - $1.12 Million
21,943 Added 4.44%
515,754 $25.5 Million
Q2 2020

Aug 13, 2020
BUY
$28.78 - $46.83 $2.34 Million - $3.8 Million
81,188 Added 19.68%
493,811 $19 Million
Q1 2020

May 14, 2020
BUY
$25.53 - $70.14 $267,426 - $734,716
10,475 Added 2.6%
412,623 $12.7 Million
Q3 2019

Nov 14, 2019
BUY
$58.58 - $83.91 $17.3 Million - $24.7 Million
294,913 Added 275.02%
402,148 $25.1 Million
Q2 2019

Aug 14, 2019
BUY
$63.59 - $78.71 $6.82 Million - $8.44 Million
107,235 New
107,235 $8.09 Million
Q2 2018

Aug 07, 2018
SELL
$27.62 - $44.51 $828,600 - $1.34 Million
-30,000 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$31.26 - $42.03 $234,450 - $315,225
7,500 Added 33.33%
30,000 $990,000
Q2 2017

Aug 14, 2017
BUY
N/A
22,500
22,500 $933,000

Others Institutions Holding GKOS

# of Institutions
355
Shares Held
50.1M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.34B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email